Andrew Easton

Dr. Andrew Easton


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2021 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
SNSaghi Nooraei
Saghi Nooraei
HBHowra Bahrulolum
Howra Bahrulolum
ZHZakieh Sadat Hoseini
Zakieh Sadat Hoseini
CKCamellia Katalani
Camellia Katalani
AHAbbas Hajizade
Abbas Hajizade
GAGholamreza Ahmadian
Gholamreza Ahmadian
Virus-like particles (VLPs) are virus-derived structures made up of one or more different molecules with the ability to self-assemble, mimicking the form and size of a virus particle but lacking the genetic material so they are not capable of infecting the host cell. Expression and self-assembly of the viral structural proteins can take place in various living or cell-free expression systems after which the viral structures can be assembled and reconstructed. VLPs are gaining in popularity in the field of preventive medicine and to date, a wide range of VLP-based candidate vaccines have been developed for immunization against various infectious agents, the latest of which is the vaccine against SARS-CoV-2, the efficacy of which is being evaluated. VLPs are highly immunogenic and are able to elicit both the antibody- and cell-mediated immune responses by pathways different from those elicited by conventional inactivated viral vaccines. However, there are still many challenges to this surface display system that need to be addressed in the future. VLPs that are classified as subunit vaccines are subdivided into enveloped and non- enveloped subtypes both of which are discussed in this review article. VLPs have also recently received attention for their successful applications in targeted drug delivery and for use in gene therapy. The development of more effective and targeted forms of VLP by modification of the surface of the particles in such a way that they can be introduced into specific cells or tissues or increase their half-life in the host is likely to expand their use in the future. Recent advances in the production and fabrication of VLPs including the exploration of different types of expression systems for their development, as well as their applications as vaccines in the prevention of infectious diseases and cancers resulting from their interaction with, and mechanism of activation of, the humoral and cellular immune systems are discussed in this review.

23 May 2016 in Archives of Virology
Verified
Journal Article
Open access
PDF file
CAClaudio L. Afonso
Claudio L. Afonso
GAGaya Amarasinghe
Gaya Amarasinghe
Krisztian BanyaiKrisztian Banyai
Krisztian Banyai
YBYīmíng Bào
Yīmíng Bào
CBChristopher F Basler
Christopher F Basler
Jens H. KuhnJens H. Kuhn
Jens H. Kuhn
In 2016, the order Mononegavirales was emended through the addition of two new families (Mymonaviridae and Sunviridae), the elevation of the paramyxoviral subfamily Pneumovirinae to family status (Pneumoviridae), the addition of five free-floating genera (Anphevirus, Arlivirus, Chengtivirus, Crustavirus, and Wastrivirus), and several other changes at the genus and species levels. This article presents the updated taxonomy of the order Mononegavirales as now accepted by the International Committee on Taxonomy of Viruses (ICTV).

14 May 2019 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
GAGaya Amarasinghe
Gaya Amarasinghe
MAMaría Angeles Ayllón
María Angeles Ayllón
YBYiming Bao
Yiming Bao
CBChristopher F Basler
Christopher F Basler
SBSina Bavari
Sina Bavari
Jens H. KuhnJens H. Kuhn
Jens H. Kuhn

15 May 2014 in Journal of Virology
Verified
Journal Article
Open access
PDF file
NDNigel J. Dimmock
Nigel J. Dimmock
AEAndrew Easton
Andrew Easton
Defective interfering (DI) RNAs are highly deleted forms of the infectious genome that are made by most families of RNA viruses. DI RNAs retain replication and packaging signals, are synthesized preferentially over infectious genomes, and are packaged as DI virus particles which can be transmitted to susceptible cells. Their ability to interfere with the replication of infectious virus in cell culture and their potential as antivirals in the clinic have long been known. However, until now, no realistic formulation has been described. In this review, we consider the early evidence of antiviral activity by DI viruses and, using the example of DI influenza A virus, outline developments that have led to the production of a cloned DI RNA that is highly active in preclinical studies not only against different subtypes of influenza A virus but also against heterologous respiratory viruses. These data suggest the timeliness of reassessing the potential of DI viruses as a novel class of antivirals that may have general applicability.

4 September 2020 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
Jens H. KuhnJens H. Kuhn
Jens H. Kuhn
SAScott Adkins
Scott Adkins
DADaniela Alioto
Daniela Alioto
SASergey Alkhovsky
Sergey Alkhovsky
GAGaya Amarasinghe
Gaya Amarasinghe
XZXueping Zhou
Xueping Zhou

7 April 2017 in Archives of Virology
Verified
Journal Article
Open access
PDF file
GAGaya Amarasinghe
Gaya Amarasinghe
YBYiming Bao
Yiming Bao
CBChristopher F Basler
Christopher F Basler
SBSina Bavari
Sina Bavari
MBMartin Beer
Martin Beer
Jens H. KuhnJens H. Kuhn
Jens H. Kuhn
In 2017, the order Mononegavirales was expanded by the inclusion of a total of 69 novel species. Five new rhabdovirus genera and one new nyamivirus genus were established to harbor 41 of these species, whereas the remaining new species were assigned to already established genera. Furthermore, non-Latinized binomial species names replaced all paramyxovirus and pneumovirus species names, thereby accomplishing application of binomial species names throughout the entire order. This article presents the updated taxonomy of the order Mononegavirales as now accepted by the International Committee on Taxonomy of Viruses (ICTV).